Cost Control Focus Continues in 2023
Josh Bindl
January 4, 2023
As a community, we accomplish more together than we can alone. The support of a community becomes even more important when faced with challenges from
National CooperativeRx
Blog
NCRx Pipeline Report Special Edition: Humira Biosimilar Update
Erica Guetzlaff
January 1, 2023
The expiration of the Humira® (adalimumab) patent has been long and enthusiastically anticipated and is finally upon us in 2023. And, as we all have
2023 Pharmacy Benefit Trends and Predictions
Wayne Salverda
December 6, 2022
2022 is coming to an end, leaving many eager to see what the new year has in store. What can we expect in the pharmacy
2022 Satisfaction Survey Results: National CooperativeRx Members and Partners
National CooperativeRx
October 21, 2022
At National CooperativeRx, we conduct an annual member and partner satisfaction survey to assess our performance, the importance of specific National CooperativeRx aspects, and the
Ricky Neault: Sales and Account Associate
National CooperativeRx
October 6, 2022
We are pleased to announce the addition of Ricky Neault to our Cooperative team! As a sales and account associate, Ricky will collaborate with our
NCRx Pipeline Report 10.1.22
Erica Guetzlaff
October 1, 2022
National CooperativeRx continually monitors the pharmaceutical pipeline. The pharmacy market is dynamic and complex, and it’s important to understand how changes may impact your plan
Sign Up for Our Newsletter
